Wales has become the latest UK nation to pause the use of puberty blockers by under-18s. The physically reversible hormone blockers, which suppress unwanted elements of puberty for young trans teens, will no longer be available to new patients, following a decision by NHS Wales. The decision comes in the wake of the publication of the Cass Report on 10 April, which looked into the model of care for trans young people in England. Alongside 32 recommendations that aim to provide a “holistic approach” to trans healthcare, the review urged “extreme caution” when it comes to prescribing hormones.